CELU Price / Book | Celularity Inc.

Celularity Inc Price/Book Ratio

The price-to-book (P/B) ratio compares what the stock market says a company is worth with what the company's own books say it is worth. It is market capitalization divided by shareholder equity, the book value left after subtracting liabilities from assets, and the table shows both amounts. A ratio of 1.0 means market value equals book value; a higher ratio means investors value the company above its net assets, often for brands, software or expected growth the books do not record. A negative ratio means equity is negative. Each point uses the filed share count and the last closing price on or before the equity's reporting date, never today's price.

Celularity Inc price/book ratio for the quarter ending 2025-12-31 was -0.83, a 115.56% decline year-over-year.
Celularity Inc price/book ratio for the quarter ending 2025-09-30 was -2.75, a 172.77% decline year-over-year.
Celularity Inc price/book ratio for the quarter ending 2025-06-30 was -1.92.
Celularity Inc price/book ratio for the quarter ending 2025-03-31 was -7.08, a 121.84% decline year-over-year.
Celularity Inc price/book ratio for fiscal 2025 was -0.83, a 115.56% decline from fiscal 2024.
Celularity Inc price/book ratio for fiscal 2024 was 5.31, a 54.59% decline from fiscal 2023.
Celularity Inc price/book ratio for fiscal 2023 was 11.69, a 1109.87% increase from fiscal 2022.
Celularity Inc price/book ratio for fiscal 2022 was 0.97, a 98.49% decline from fiscal 2021.

Available history: 2019-09-30 to 2025-12-31
Data captured: 2025-12-31

Historical Price/Book Ratio

Date	Price/Book Ratio	Market capitalization	Shareholder equity
2025-12-31	-0.83	$31.43M	-$38.06M
2025-09-30	-2.75	$55.25M	-$20.09M
2025-06-30	-1.92	$48.86M	-$25.5M
2025-03-31	-7.08	$39.01M	-$5.51M
2024-12-31	5.31	$46.9M	$8.84M
2024-09-30	3.78	$65.29M	$17.28M
2024-03-31	32.44	$1.01B	$31.25M
2023-12-31	11.69	$478.64M	$40.96M
2023-09-30	14.01	$423.9M	$30.25M
2023-06-30	8.12	$962.23M	$118.5M
2023-03-31	6.57	$1.02B	$155.63M
2022-12-31	0.97	$192.11M	$198.9M
2022-09-30	20.03	$3.29B	$164.24M
2022-06-30	31.32	$4.7B	$150.15M
2022-03-31	133.42	$12B	$89.91M
2021-12-31	64.02	$6.36B	$99.42M
2021-09-30	90.85	$8.74B	$96.22M
2021-03-31	-3.05	$1.87B	-$611.93M
2020-12-31	-3.84	$2.04B	-$531.4M
2020-03-31	-0.87	$310.32M	-$356.78M
2019-12-31	-0.96	$315.07M	-$327.42M
2019-09-30	572.12	$2.86B	$5M

Annual Price/Book Ratio

Date	Price/Book Ratio	Market capitalization	Shareholder equity
2025-12-31	-0.83	$31.43M	-$38.06M
2024-12-31	5.31	$46.9M	$8.84M
2023-12-31	11.69	$478.64M	$40.96M
2022-12-31	0.97	$192.11M	$198.9M
2021-12-31	64.02	$6.36B	$99.42M
2020-12-31	-3.84	$2.04B	-$531.4M
2019-12-31	-0.96	$315.07M	-$327.42M

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
CervoMed Inc. (CRVO)	United States	$0.038B	-1.39
Actinium Pharmaceuticals, Inc. (ATNM)	United States	$0.038B	2.73
FILANA THERAPEUTICS, INC. (FLNA)	United States	$0.038B	-1.05
PMGC Holdings Inc. (ELAB)	United States	$0.037B
Edesa Biotech, Inc. (EDSA)	Canada	$0.039B
BriaCell Therapeutics Corp. (BCTX)		$0.037B
Karyopharm Therapeutics Inc. (KPTI)	United States	$0.039B	-0.98
Seres Therapeutics, Inc. (MCRB)	United States	$0.036B	-3.45
MIRA PHARMACEUTICALS, INC. (MIRA)	United States	$0.036B	-4.30
Incannex Healthcare Inc. (IXHL)		$0.040B	-22.32